Leukotrienes and blood-brain barrier
Leukotrienes and blood-brain barrier
批准号:
8451256
负责人:
Kwang S Kim
金额:
$38.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-15 至 2015-04-30
关键词:
ActinsAdherens JunctionAffectAllergic DiseaseArachidonate 5-LipoxygenaseBloodBlood - brain barrier anatomyBlood capillariesBrainBreathingCardiovascular DiseasesCell physiologyCellsCentral Nervous System InfectionsCerebrumCollagenCryptococcus neoformansCytoskeletonCytosolic Phospholipase A2DNA Sequence RearrangementDevelopmentElectrical ResistanceEndothelial CellsEscherichia coliExhibitsExperimental Animal ModelFamilyFungemiaGene DeletionHumanIn VitroLeadLeukotrienesLifeLung diseasesMeningitisMeningoencephalitisModelingOrganOrganismPenetrationPermeabilityPinocytosisPropertyProtein Kinase CProtein-Serine-Threonine KinasesProteinsRegulationResourcesRoleSepsisSignal TransductionSignal Transduction PathwaySignaling MoleculeTight JunctionsTimebasecapillarycysteinyl-leukotrieneinnovationmicrobialmicroorganismmonolayernovelpathogenpreventpublic health relevancereceptorrelating to nervous system
中文摘要
描述(由申请人提供):微生物穿越血脑屏障是中枢神经系统感染发展所必需的,但其潜在机制尚不完全清楚。血脑屏障是由脑微血管内皮细胞形成的结构和功能屏障,保护大脑免受血液中循环的任何微生物的侵害,但最近的研究表明,引起脑膜炎的病原体能够作为活生物体穿过血脑屏障。通过分离培养人脑微血管内皮细胞(HBMEC),建立了体外血脑屏障模型。在胶原包被的Transwell插入物上培养后,HBMEC单层表现出紧密连接形成和极性单层的形态和功能特性。我们的初步研究表明,通过经内皮电阻和通透性评估,引起脑膜炎的病原体穿过HBMEC单层而不影响HBMEC的完整性,微生物穿过HBMEC单层涉及特定的宿主信号转导途径。我们使用药物抑制和基因缺失的进一步初步研究首次表明宿主5-脂氧合酶可能参与微生物穿越血脑屏障。白三烯由5-脂氧合酶合成,在呼吸系统疾病、过敏性疾病和心血管疾病中具有病理生理作用,但在微生物穿越血脑屏障中的作用尚未被探索。我们对受体拮抗剂的初步研究表明,半胱氨酸白三烯可能参与微生物穿越血脑屏障。本应用程序的总体目的是研究和表征参与微生物穿越血脑屏障的宿主信号分子。从这个应用中得到的信息将证明5-脂氧合酶和白三烯对微生物穿越血脑屏障的新贡献。
英文摘要
DESCRIPTION (provided by applicant): Microbial traversal of the blood-brain barrier is required for the development of central nervous system infection, but the underlying mechanisms remain incompletely understood. The blood-brain barrier is a structural and functional barrier that is formed by brain microvascular endothelial cells and protects the brain from any microorganisms circulating in the blood, but recent studies have shown that meningitis-causing pathogens are able to cross the blood-brain barrier as live organisms. We have developed the in vitro blood-brain barrier model by isolation and cultivation of human brain microvascular endothelial cells (HBMEC). Upon cultivation on collagen-coated Transwell inserts the HBMEC monolayers exhibit morphological and functional properties of tight junction formation and polar monolayer. Our Preliminary Studies revealed that meningitis-causing pathogens traverse the HBMEC monolayers without affecting the HBMEC integrity, as assessed by transendothelial electrical resistance and permeability, and microbial traversal of the HBMEC monolayers involves specific host signal transduction pathways. Our additional Preliminary Studies using pharmacological inhibition and gene deletion suggest for the first time that host 5-lipoxygenase is likely to be involved in microbial traversal of the blood-brain barrier. Leukotrienes are synthesized by 5-lipoxygenase and shown to have pathophysiological roles in respiratory diseases, allergic diseases and cardiovascular diseases, but their role in microbial traversal of the blood-brain barrier has not been explored. Our Preliminary Studies with the receptor antagonists revealed that cysteinyl leukotrienes are likely to be involved in microbial traversal of the blood-brain barrier. The overall aim of this application is to investigate and characterize the host signaling molecules involved in microbial traversal of the blood- brain barrier. The information derived from this application will demonstrate the novel contributions of 5- lipoxygenase and leukotrienes to microbial traversal of the blood-brain barrier.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cryptococcal Exploitation of the Blood-Brain Barrier
-
批准号:10012330
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2020
-
负责人:Kwang S Kim
-
依托单位:
E. coli penetration of the blood-brain barrier
-
批准号:9243956
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2016
-
负责人:Kwang S Kim
-
依托单位:
Pathogenesis of bacterial meningitis
-
批准号:9303283
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2016
-
负责人:Kwang S Kim
-
依托单位:
Discovery of Novel Therapeutics for Fungal Pathogens
-
批准号:9393966
-
项目类别:
-
资助金额:$20.2万
-
财政年份:2016
-
负责人:Kwang S Kim
-
依托单位:
Pathogenesis of bacterial meningitis
-
批准号:9167645
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2016
-
负责人:Kwang S Kim
-
依托单位:
E. coli penetration of the blood-brain barrier
-
批准号:9034789
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2016
-
负责人:Kwang S Kim
-
依托单位:
Host factors and bacterial meningitis
-
批准号:9028219
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2015
-
负责人:Kwang S Kim
-
依托单位:
Host factors and bacterial meningitis
-
批准号:9270628
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2015
-
负责人:Kwang S Kim
-
依托单位:
Leukotrienes and blood-brain barrier
-
批准号:8640878
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:Kwang S Kim
-
依托单位:
Leukotrienes and blood-brain barrier
-
批准号:8071224
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:Kwang S Kim
-
依托单位:
Leukotrienes and blood-brain barrier
-
批准号:8259454
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:Kwang S Kim
-
依托单位:
Leukotrienes and blood-brain barrier
-
批准号:7983031
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2010
-
负责人:Kwang S Kim
-
依托单位:
Research Training in Pediatric Infectious Diseases
-
批准号:7287602
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2007
-
负责人:Kwang S Kim
-
依托单位:
Research Training in Pediatric Infectious Diseases
-
批准号:7892285
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2007
-
负责人:Kwang S Kim
-
依托单位:
Research Training in Pediatric Infectious Diseases
-
批准号:7493438
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2007
-
负责人:Kwang S Kim
-
依托单位:
Research Training in Pediatric Infectious Diseases
-
批准号:7664540
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2007
-
负责人:Kwang S Kim
-
依托单位:
Research Training in Pediatric Infectious Diseases
-
批准号:8099061
-
项目类别:
-
资助金额:$7.82万
-
财政年份:2007
-
负责人:Kwang S Kim
-
依托单位:
Genome-wide screening of E. coli for bacteremia
-
批准号:7167396
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2006
-
负责人:Kwang S Kim
-
依托单位:
Genome-wide screening of E. coli for bacteremia
-
批准号:7244046
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2006
-
负责人:Kwang S Kim
-
依托单位:
Cryptococcus traversal of Brain Endothelial cells
-
批准号:7061961
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2005
-
负责人:Kwang S Kim
-
依托单位:
海外基金